Virginia 2026 Regular Session

Virginia House Bill HB360

Introduced
1/12/26  
Refer
1/12/26  
Report Pass
2/12/26  
Report Pass
2/13/26  
Engrossed
2/16/26  
Refer
2/18/26  
Report Pass
2/25/26  
Engrossed
3/2/26  
Enrolled
3/5/26  
Engrossed
3/2/26  
Chaptered
4/13/26  
Engrossed
3/2/26  

Caption

An Act to amend and reenact ยง 59.1-200 of the Code of Virginia, relating to Virginia Consumer Protection Act; prohibited practices; kratom products.

Impact

If enacted, HB360 would amend existing consumer protection laws in Virginia to specifically address the sale of kratom products. It would prohibit the sale of kratom products to individuals under 21 years of age and requires these products to be labeled with health warnings indicating that the product may be harmful to health and has not been evaluated by the FDA. Retailers would need to ensure that kratom products are stored in secured areas to prevent unauthorized access, thus enhancing consumer safety and enabling better oversight of these potentially addictive substances.

Summary

House Bill 360, known as the Virginia Consumer Protection Act regarding prohibited practices around kratom products, seeks to establish regulations and restrictions in the sale and marketing of kratom in the state of Virginia. The bill aims to protect consumers from potential risks associated with kratom, a substance derived from the leaves of the Mitragyna speciosa plant, which has been reported to have both stimulant and sedative effects. By addressing issues such as misbranding and age restrictions, HB360 emphasizes the need for clear labeling and appropriate sales practices for these products.

Sentiment

The sentiment surrounding HB360 is mixed. Supporters of the bill argue that it is a necessary step in safeguarding public health, especially in the light of rising concerns regarding the safety and regulation of kratom. They stress that appropriate regulations can help prevent misuse among younger populations. Conversely, critics express concern that overly stringent regulations may limit consumer access to a product that some adults use responsibly for various reasons, including pain management and anxiety relief. This has led to debates about the balance between consumer protection and personal freedom.

Contention

Notable points of contention in the discussions around HB360 include the extent of the health warnings and the implications of the age restrictions on consumer rights. Some stakeholders argue that while consumer protection is essential, the measures proposed by the bill may disproportionately affect responsible adult users of kratom, potentially leading to market restrictions. There's a call for further studies and a more nuanced approach to regulating kratom, rather than outright prohibitions. The discussions reveal a complex landscape where public health concerns intersect with individual liberties and market considerations.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.